Generic vs Brand Names

Foundational Distinctions Between Generic and Brand Medications

One of the first concepts a pharmacy technician must master is the difference between generic and brand-name medications. Understanding this distinction is critical for accurately processing prescriptions, minimizing dispensing errors, and ensuring patient safety.^[1] Exam questions often test your ability to identify the generic name when given a brand name—and vice versa—as well as your knowledge of the regulatory and bioequivalence standards that govern generic drug approval.

Official Naming Standards: Brand, Generic, and Chemical Identifiers

Brand Name (Trade Name)

The proprietary name given to a drug by its manufacturer.
Protected by a patent (typically 20 years from filing).
Examples: Tylenol (brand) vs. acetaminophen (generic), Lipitor (brand) vs. atorvastatin (generic).

Generic Name

The official, nonproprietary name assigned by the United States Adopted Names (USAN) Council.^[2]
Usually the same as the active ingredient's chemical name, but simplified.
Once a patent expires, other manufacturers can produce a bioequivalent version sold under the generic name.

Chemical Name

Describes the molecular structure of the drug.
Rarely used in pharmacy practice; only appears in drug references.

High-yield exam tip: The generic name is the same drug, but it may look different because of inactive ingredients (fillers, dyes). The active ingredient must be identical to meet FDA standards.

Regulatory Framework for Generic Drug Approval and Dispensing

Patent and Exclusivity Period

New drug is developed and patented by the innovator company.
During the patent period, only the innovator can market the drug under its brand name.
After patent expiration (and after any market exclusivity granted by the FDA), other companies can apply to manufacture a generic version.^[3]

FDA Approval Process for Generics – Abbreviated New Drug Application (ANDA)

The generic manufacturer must demonstrate bioequivalence to the brand-name product.
Bioequivalence means the generic delivers the same amount of active ingredient into the bloodstream at the same rate as the brand.^[4]
Generic drugs do not need to repeat years of clinical trials; they rely on the safety and efficacy data of the brand product.
The FDA requires that generics be within 80%–125% of the brand’s bioavailability, but most generics fall well within a tighter range.

Differences That Are Allowed

Shape, color, size, and markings – these can differ from the brand.
Inactive ingredients (fillers, binders, preservatives) – these may differ but must not affect therapeutic outcome.
Manufacturer’s name – each manufacturer uses its own label.

When Substitution Is Allowed

Most states allow (or require) a pharmacist to dispense a generic unless the prescriber writes “DAW” (Dispense As Written) or “Brand Medically Necessary.”^[5]
A pharmacy technician must always verify the prescriber’s intent and check the state’s substitution laws.

Operational Management of Generic and Brand Prescriptions

Prescription Processing

Enter the drug as prescribed (brand or generic).
If the doctor wrote the brand but the pharmacy policy requires generic substitution, the technician must notify the pharmacist to check for DAW codes.
Technicians must double-check the NDC (National Drug Code) to ensure the correct product is selected.

Patient Counseling (Technician Role)

Technicians often assist by explaining that the generic is the same medication as the brand, just made by a different company.
Emphasize that the active ingredient is identical.
If a patient reports that the generic “doesn’t work the same,” the technician must document and refer the patient to the pharmacist.^[6]

Dispensing Errors

Look-alike, sound-alike (LASA) drugs are common errors.
Example: celexa (citalopram – an antidepressant) vs. celebrex (celecoxib – an NSAID). Both are generic names, but they sound similar. Always confirm using the brand name if there is doubt.
Use tall-man lettering on labels and storage bins (e.g., HYDROxyzine vs. HYDROchlorothiazide).^[7]

Risks from NTI Drugs and Excipient Allergies

Narrow therapeutic index (NTI) drugs: Even small differences in bioavailability can affect patient outcomes. Examples: warfarin, levothyroxine, digoxin. Some states require that only the brand be dispensed for NTI drugs unless the prescriber approves generic.^[4]
Allergic reactions: A patient may react to an inactive ingredient in the generic that is different from the brand. The technician must flag this for the pharmacist.
Patient confusion: Different colors/shapes of generics can cause patients to think they received the wrong medication. Reassure them using the strength and generic name as confirmation.

Essential Brand-Generic Pairs and Regulatory Exam Topics

Memorize top brand–generic pairs: The PTCE frequently tests: Prilosec (omeprazole), Zocor (simvastatin), Norvasc (amlodipine), Synthroid (levothyroxine), Xanax (alprazolam).
Know the ANDA process: “Abbreviated New Drug Application” is a common multiple-choice question.
Bioequivalence range: Remember 80–125% but understand that it’s the confidence interval for the ratio of means, not an acceptable deviation per patient.
Orange Book: The FDA’s Approved Drug Products with Therapeutic Equivalence Evaluations lists all approved generics and their therapeutic equivalence ratings (A-rated generics are interchangeable).^[3]
DAW codes: Code 1 (prescriber requires brand), Code 2 (patient requested brand), Code 3 (pharmacist chooses brand). Know them for the exam.

Quick-Reference Table: Common Brand–Generic Pairs for the PTCE

Brand Name	Generic Name	Therapeutic Class
Lipitor	Atorvastatin	Statin (antihyperlipidemic)
Prilosec	Omeprazole	Proton pump inhibitor
Zocor	Simvastatin	Statin
Synthroid	Levothyroxine	Thyroid hormone
Xanax	Alprazolam	Benzodiazepine
Norvasc	Amlodipine	Calcium channel blocker (antihypertensive)
Glucophage	Metformin	Antidiabetic (biguanide)